Phospholipid Profiles in Breast Tissues
Author Information
Author(s): T.E. Merchant, P. Meneses, L.W. Gierke, W. Den Otter, T. Glonek
Primary Institution: Pathologisch Instituut, Rijksuniversiteit Utrecht; MR Laboratory and Department of Pathology, Chicago College of Osteopathic Medicine
Hypothesis
Can phospholipid profiles differentiate between malignant, benign, and noninvolved breast tissues?
Conclusion
The study found distinct phospholipid profiles that can help differentiate malignant from benign and noninvolved breast tissues.
Supporting Evidence
- 92% of benign tissue cases were correctly predicted using phospholipid profiles.
- Phosphatidylethanolamine was significantly elevated in malignant tissues compared to benign and noninvolved.
- Lysophosphatidylcholine was significantly decreased in malignant tissues compared to noninvolved.
- Distinct phospholipid patterns were observed among malignant, benign, and noninvolved tissues.
Takeaway
This study looked at the fats in breast tissues to see if they can tell the difference between healthy and sick tissues.
Methodology
Phospholipids were extracted from breast tissues and analyzed using 31P MR spectroscopy.
Limitations
The study only included patients with no previous history of malignancy.
Participant Demographics
Included 18 malignant specimens, 25 benign specimens, and 12 noninvolved specimens.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website